Vaccines Europe pipeline review 2024
This report covers the period from August 2023 to August 2024, highlighting the latest developments within the vaccine industry and how these innovations are addressing existing and upcoming health threats.
News
Policy & Recommendations
Cardiovascular health: Council calls for more robust efforts to help prevent cardiovascular diseases
In conclusions recently approved, the Council puts forward a series of measures aimed at improving cardiovascular health in the EU, focusing specifically on prevention, early detection, treatment and rehabilitation.
European Specialist Nurses Organisation: Video campaign on essential vaccination practices
A three-part series focusing on essential vaccination practices. It covers key aspects such as understanding vaccine protocols, ensuring proper documentation and record-keeping, and effective communication with patients.
News
Policy & Recommendations
Flu Awareness Campaign 2024
Held annually in October, this campaign aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
News
Policy & Recommendations
ESWI Science Policy Interface Roundtable
Hosted by the Parliament of the Czech Republic in Prague and ESWI Board Member Roman Prymula, the event brought together key stakeholders in the Czech Republic to discuss and address the critical issues surrounding vaccine uptake.
Respiratory infections: how does a virus spread inside a body and through the population?
Four Joint Research Centre (JRC) designed epidemiological and viral kinetics models will enhance understanding of respiratory disease dynamics, contributing to a better preparedness of future infectious disease outbreaks.
Call to Action: Respiratory virus infections and cardiovascular disease (CVD)
Vaccination against respiratory viruses can reduce the risk of complications associated with CVDs.
Three new studies probe the efficacy of antivirals in preventing and treating influenza
Two find that the drugs may shorten hospital stays and decrease the risk of infection in those at high risk for severe illness, and one concludes that timely initiation reduces the risk of death from flu-related pneumonia.
When should you take antiviral drugs?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
What is the difference between monovalent and polyvalent vaccines?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Which viruses could cause the next pandemic?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
Will individuals need an annual COVID-19 vaccination?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.